An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida
Clinical Microbiology Reviews · 11.12.2025 · 38 (4)
DOI: 10.1128/cmr.00064-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 11.12.2025. Verfasst von Elaine Cristina Francisco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Candida, Ascomycota, Mycoses. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 392 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Many yeast species causing life-threatening invasive infections that were formerly classified in the genus Candida have been reclassified due to their evolutionary and phylogenetic relationships elucidated by DNA sequencing methods that are increasingly using whole genomes. This review explores the evolving taxonomy, epidemiology, and clinical implications of clinically relevant, rare, emerging Candida and Saccharomycotina yeasts that have recently been reclassified from Candida . This article highlights the urgent need for intensified research efforts to enhance knowledge and improve outcomes in the management of infections caused by these yeasts. Communicating results from molecular phylogenetic studies of yeasts, which lead to their reclassification, is of great importance to the medical mycology community to implement such results in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, Brazil.
- Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.
- Center of Expertise in Mycology Radboudumc/Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
- IMMY, Norman, Oklahoma, USA.
- Ministry of Public Health and Social Welfare, National Leprosy Control Program, National Directorate of Health Surveillance, Dermatology Specialty Center, San Lorenzo, Paraguay.
- Laboratorio de Micología y Diagnóstico Molecular, Cátedra de Parasitología y Micología, Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, CONICET, Santa Fe, Argentina.
ORCID-Profile: Elaine Cristina Francisco, Felipe de Camargo Ribeiro, Matheus Naves de Almeida, João Nóbrega de Almeida, Cornelia Lass-Flörl, Teun Boekhout, Arnaldo Lopes Colombo
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Francisco, E. C., Caceres, D. H., Brunelli, J. G. P., Garcia-Effron, G., Arastehfar, A., Ribeiro, F. C., de Almeida, M. N., Gonçalves, S. S., Nóbrega de Almeida, J., Lass-Flörl, C., Boekhout, T., & Colombo, A. L. (2025). An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida. Clinical Microbiology Reviews, 38(4). https://doi.org/10.1128/cmr.00064-23
Vancouver
Francisco EC, Caceres DH, Brunelli JGP, Garcia-Effron G, Arastehfar A, Ribeiro FC, et al. An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida. Clinical Microbiology Reviews. 2025;38(4). doi:10.1128/cmr.00064-23
BibTeX
@article{Francisco2025,
author = {Francisco, Elaine Cristina and Caceres, Diego H and Brunelli, José Guillermo Pereira and Garcia-Effron, Guillermo and Arastehfar, Amir and Ribeiro, Felipe de Camargo and de Almeida, Matheus Naves and Gonçalves, Sarah Santos and Nóbrega de Almeida, João and Lass-Flörl, Cornelia and Boekhout, Teun and Colombo, Arnaldo Lopes},
title = {An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida},
journal = {Clinical Microbiology Reviews},
year = {2025},
volume = {38},
number = {4},
doi = {10.1128/cmr.00064-23}
}
EUVIMED